Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-04-06 @ 6:28 AM
Study NCT ID:
NCT00612950
Status:
COMPLETED
Last Update Posted:
2008-02-12
First Post:
2008-01-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Beta-Cell Function After Near-Normalisation of Blood Glucose
Sponsor:
Hvidovre University Hospital
Organization:
Study Overview
Official Title:
Four Weeks of Near Normalisation of Blood Glucose Improves the Insulin Response to GLP-1 and GIP in Patients With Type 2 Diabetes
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 respectively. The aim of the present study was to investigate whether 4 weeks of near-normalization of blood glucose could improve the insulin responses to GIP and GLP-1 in patients with type 2 diabetes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| KA 03005 | None | None | View |